Figure 2From: Arteriogenic therapy based on simultaneous delivery of VEGF-A and FGF4 genes improves the recovery from acute limb ischemiaTherapeutic transgenes are overexpressed in mouse skeletal muscles. Quantitative PCR for (A) hVEGF-A and (B) hFGF4. EF2 served as a constitutive control gene. Values are means ± SEM (n = 3-4 per group and per time-point). * p < 0.05 vs AAV-LacZ at the appropriate time point. # p < 0.05 vs AAV-VEGF-A.Back to article page